US 11708347
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted A61KA61K9/50A61P
Quick answer
US patent 11708347 (Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors) held by BioCryst Pharmaceuticals, Inc. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K9/50, A61P, A61P13/12, A61P25/28